Insulin Degludec / Insulin Aspart

New Delhi: A day after the central drug regulator issued an alert over the reported theft of Novo Nordisk’s Wegovy and insulin batches, the company has advised patients to purchase its medicines only from authorised pharmacies . In its statement, the drugmaker said, “We are aware of the unfortunate theft of a minor quantity of Novo Nordisk medications during transportation by our distribution partners. The incident has been reported to the relevant authorities, and we are fully cooperating with the ongoing investigation.” The statement further added, “To protect patient well-being and ensure authenticity of products, we urge all individuals to purchase Novo Nordisk medications only from authorised pharmacies, accompanied by a valid prescription and invoice.” The announcement comes in the wake of an alert issued by the country’s apex drug regulator, the DCGI, after the company reported that three batches of its insulin brands Ryzodeg and Fiasp along with three batches of Wegovy (0.25 mg, 0.5 mg, and 1 mg) were stolen while in transit from its Bhiwandi hub to distribution routes including Nagpur, Raipur, Cuttack, and Kolkata. Following the disclosure, the regulator directed state drug controllers “to maintain strict surveillance over the movement of the specified products in the market and to take necessary action under the provisions of the Drugs & Cosmetics Act, 1940, and its Rules.” Meanwhile, Novo Nordisk said, “We have taken additional measures, along with our distribution partners and the authorities, to strengthen safeguards across our supply chain and prevent similar situations in the future.” By Online Bureau ,

New Delhi: Danish drugmaker Novo Nordisk has reported a theft of several batches of its insulin and Wegovy injections during transit from its Bhiwandi hub to distribution routes. Reporting the incident to the central drug regulator, CDSCO, the drugmaker informed that three batches of its insulin brands—Ryzodeg and Fiasp along with three batches of Wegovy–0.25 mg, 0.5 mg, and 1 mg–each were stolen while in transit from its Bhiwandi hub to milk route (distribution routes) including Nagpur, Raipur, Cuttack, and Kolkata. Currently the matter is under a police investigation. Issuing a safety alert, the Drugs Controller General of India (DCGI) stressed that the stolen formulations are rDNA injectables , which require stringent temperature controls. Improper storage could compromise product quality and pose serious risks to patient safety . The DCGI has directed state drug controllers to maintain strict surveillance over the movement of these products in the market and take necessary action under the Drugs & Cosmetics Act, 1940, and its Rules. Healthcare professionals have been advised to educate patients on reporting any adverse events and to ensure procurement only from authorized sources with valid invoices. Issuing a statement over the matter the company said, "the incident has been reported to the relevant authorities, and we are fully cooperating with the ongoing investigation." "Patient safety is and will be our top priority. Our rigorous cold chain and quality assurance measures ensure medications are stored at the required temperature to maintain their integrity and effectiveness," it added. While Novo Nordisk’s insulin brands are well established in India, Wegovy—a blockbuster GLP-1 drug indicated for weight loss—was launched in the country in June this year. By Online Bureau ,